Amgen Inc. has broken ground on a $600 million state-of-the-art Center for Science and Innovation at its global headquarters in Thousand Oaks, California. The new facility will integrate research and process development teams to accelerate the transition from drug discovery to commercial manufacturing, aiming to speed up the delivery of transformative therapies for patients with serious diseases. The expansion is expected to bring highly skilled jobs and further innovation to the Thousand Oaks and Greater Los Angeles area, reinforcing Amgen's long-standing commitment to the local community and its mission to serve patients worldwide.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief on October 31, 2025, and is solely responsible for the information contained therein.